{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:03:30Z","timestamp":1793322210964,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s11606-023-08383-1","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T13:01:42Z","timestamp":1693918902000},"page":"95-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Telehealth Initiation of Buprenorphine for Opioid Use Disorder: Patient Characteristics and Outcomes"],"prefix":"10.1007","volume":"39","author":[{"given":"Binh","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0098-7944","authenticated-orcid":false,"given":"Winnie","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"key":"8383_CR1","volume-title":"Medications for Opioid Use Disorder Save Lives","author":"National Academies of Sciences Engineering and Medicine","year":"2019","unstructured":"National Academies of Sciences Engineering and Medicine. Medications for Opioid Use Disorder Save Lives. Washington, DC: The National Academies Press; 2019."},{"issue":"9","key":"8383_CR2","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/jamapsychiatry.2016.1390","volume":"73","author":"A Lembke","year":"2016","unstructured":"Lembke A, Chen JH. Use of Opioid Agonist Therapy for Medicare Patients in 2013. JAMA Psychiatry. 2016;73(9):990-992.","journal-title":"JAMA Psychiatry."},{"issue":"7","key":"8383_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/MLR.0000000000000727","volume":"55","author":"B Saloner","year":"2017","unstructured":"Saloner B, Daubresse M, Caleb Alexander G. Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population. Med Care. 2017;55(7):669-676.","journal-title":"Med Care."},{"issue":"3","key":"8383_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2105\/AJPH.2018.304856","volume":"109","author":"CM Andrews","year":"2019","unstructured":"Andrews CM, Abraham AJ, Grogan CM, Westlake MA, Pollack HA, Friedmann PD. Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs. Am J Public Health. 2019;109(3):434-436.","journal-title":"Am J Public Health."},{"issue":"11","key":"8383_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.23677","volume":"3","author":"J Ballreich","year":"2020","unstructured":"Ballreich J, Mansour O, Hu E, et al. Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US. JAMA Netw Open. 2020;3(11):e2023677.","journal-title":"JAMA Netw Open."},{"issue":"8","key":"8383_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1176\/appi.ps.201900444","volume":"71","author":"TB Creedon","year":"2020","unstructured":"Creedon TB, Schrader KE, O'Brien PL, Lin JR, Carroll CD, Mulvaney-Day N. Rural-Nonrural Differences in Telemedicine Use for Mental and Substance Use Disorders Among Medicaid Beneficiaries. Psychiatr Serv. 2020;71(8):756-764.","journal-title":"Psychiatr Serv."},{"issue":"9","key":"8383_CR7","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.mayocp.2018.07.001","volume":"93","author":"YT Yang","year":"2018","unstructured":"Yang YT, Weintraub E, Haffajee RL. Telemedicine's Role in Addressing the Opioid Epidemic. Mayo Clin Proc. 2018;93(9):1177-1180.","journal-title":"Mayo Clin Proc."},{"issue":"12","key":"8383_CR8","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1377\/hlthaff.2018.05134","volume":"37","author":"HA Huskamp","year":"2018","unstructured":"Huskamp HA, Busch AB, Souza J, et al. How Is Telemedicine Being Used In Opioid And Other Substance Use Disorder Treatment? Health Aff (Millwood). 2018;37(12):1940-1947.","journal-title":"Health Aff (Millwood)."},{"issue":"1","key":"8383_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.7326\/M20-1141","volume":"173","author":"GC Alexander","year":"2020","unstructured":"Alexander GC, Stoller KB, Haffajee RL, Saloner B. An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19. Ann Intern Med. 2020;173(1):57-58.","journal-title":"Ann Intern Med."},{"issue":"1","key":"8383_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jrh.12307","volume":"35","author":"CHA Andrilla","year":"2019","unstructured":"Andrilla CHA, Moore TE, Patterson DG, Larson EH. Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update. J Rural Health. 2019;35(1):108-112.","journal-title":"J Rural Health."},{"key":"8383_CR11","unstructured":"Prevoznik TW. Letter Regarding Use of Telephone Evaluations to Initiate Buprenorphine Prescribing. In: Drug Enforcement Administration, ed. DEA068. Springfield, Virginia: U.S. Department of Justice; 2020."},{"issue":"1","key":"8383_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.42531","volume":"5","author":"BA Barsky","year":"2022","unstructured":"Barsky BA, Busch AB, Patel SY, Mehrotra A, Huskamp HA. Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage. JAMA Netw Open. 2022;5(1):e2142531.","journal-title":"JAMA Netw Open."},{"issue":"9","key":"8383_CR13","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1001\/jamapsychiatry.2022.1776","volume":"79","author":"CM Jones","year":"2022","unstructured":"Jones CM, Compton WM, Han B, Baldwin G, Volkow ND. Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs. JAMA Psychiatry. 2022;79(9):932-934.","journal-title":"JAMA Psychiatry."},{"issue":"10","key":"8383_CR14","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1001\/jamapsychiatry.2022.2284","volume":"79","author":"CM Jones","year":"2022","unstructured":"Jones CM, Shoff C, Hodges K, et al. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic. JAMA Psychiatry. 2022;79(10):981-992.","journal-title":"JAMA Psychiatry."},{"key":"8383_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.genhosppsych.2020.09.004","volume":"67","author":"J Yang","year":"2020","unstructured":"Yang J, Landrum MB, Zhou L, Busch AB. Disparities in outpatient visits for mental health and\/or substance use disorders during the COVID surge and partial reopening in Massachusetts. Gen Hosp Psychiatry. 2020;67:100-106.","journal-title":"Gen Hosp Psychiatry."},{"key":"8383_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.557275","volume":"8","author":"TO Cole","year":"2020","unstructured":"Cole TO, Robinson D, Kelley-Freeman A, et al. Patient Satisfaction With Medications for Opioid Use Disorder Treatment via Telemedicine: Brief Literature Review and Development of a New Assessment. Front Public Health. 2020;8:557275.","journal-title":"Front Public Health."},{"key":"8383_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108272","volume":"124","author":"L Wang","year":"2021","unstructured":"Wang L, Weiss J, Ryan EB, Waldman J, Rubin S, Griffin JL. Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic. J Subst Abuse Treat. 2021;124:108272.","journal-title":"J Subst Abuse Treat."},{"issue":"2","key":"8383_CR18","first-page":"5","volume":"23","author":"E Weintraub","year":"2021","unstructured":"Weintraub E, Greenblatt AD, Chang J, et al. Outcomes for patients receiving telemedicine-delivered medication-based treatment for Opioid Use Disorder: A retrospective chart review. Heroin Addict Relat Clin Probl. 2021;23(2):5-12.","journal-title":"Heroin Addict Relat Clin Probl."},{"issue":"7,Supplement","key":"8383_CR19","doi-asserted-by":"publisher","first-page":"S596","DOI":"10.1016\/j.jval.2022.04.1630","volume":"25","author":"R Avula","year":"2022","unstructured":"Avula R, Grabner M, Eshete B, Stanek E, Willey V. RWD106 Characterizing Telehealth Utilization from Administrative Claims in the US Using a Standardized Definition. Value in Health. 2022;25(7, Supplement):S596.","journal-title":"Value in Health."},{"key":"8383_CR20","unstructured":"Federal Communications Commission. Mapping Broadband Health in America. 2020; https:\/\/www.fcc.gov\/health\/maps. Accessed 2020."},{"key":"8383_CR21","unstructured":"Robert Wood Johnson Foundation. County Health Ranking Data. 2022; https:\/\/www.countyhealthrankings.org\/. Accessed 2022."},{"issue":"1","key":"8383_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12913-020-05999-5","volume":"21","author":"N Sharma","year":"2021","unstructured":"Sharma N, Schwendimann R, Endrich O, Ausserhofer D, Simon M. Comparing Charlson and Elixhauser comorbidity indices with different weightings to predict in-hospital mortality: an analysis of national inpatient data. BMC Health Serv Res. 2021;21(1):13.","journal-title":"BMC Health Serv Res."},{"key":"8383_CR23","unstructured":"NCQA. Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment (IET). 2022; https:\/\/www.ncqa.org\/hedis\/measures\/initiation-and-engagement-of-alcohol-and-other-drug-abuse-or-dependence-treatment\/. Accessed April 11, 2023."},{"issue":"3","key":"8383_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.3821","volume":"5","author":"PM Mauro","year":"2022","unstructured":"Mauro PM, Gutkind S, Annunziato EM, Samples H. Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019. JAMA Netw Open. 2022;5(3):e223821.","journal-title":"JAMA Netw Open."},{"issue":"5","key":"8383_CR25","first-page":"444","volume":"321","author":"R Voelker","year":"2019","unstructured":"Voelker R. App Aids Treatment Retention for Opioid Use Disorder. Jama. 2019;321(5):444.","journal-title":"Jama."},{"issue":"5","key":"8383_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/archinternmed.2010.541","volume":"171","author":"DP Alford","year":"2011","unstructured":"Alford DP, LaBelle CT, Kretsch N, et al. Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience. Arch Intern Med. 2011;171(5):425-431.","journal-title":"Arch Intern Med."},{"issue":"11","key":"8383_CR27","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/jamapediatrics.2018.2143","volume":"172","author":"SE Hadland","year":"2018","unstructured":"Hadland SE, Bagley SM, Rodean J, et al. Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder. JAMA Pediatr. 2018;172(11):1029-1037.","journal-title":"JAMA Pediatr."},{"issue":"12","key":"8383_CR28","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s11606-019-05251-9","volume":"34","author":"H Englander","year":"2019","unstructured":"Englander H, Dobbertin K, Lind BK, et al. Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis. J Gen Intern Med. 2019;34(12):2796-2803.","journal-title":"J Gen Intern Med."},{"issue":"40","key":"8383_CR29","first-page":"12890","volume":"88","author":"Drug Enforcement Administration","year":"2023","unstructured":"Drug Enforcement Administration. Expansion of Induction of Buprenorphine via Telemedicine Encounter. A Proposed Rule by the Drug Enforcement Administration on 03\/01\/2023. Federal Register. 2023;88(40):12890-12906.","journal-title":"Federal Register."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-023-08383-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-023-08383-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-023-08383-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T20:03:30Z","timestamp":1725480210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-023-08383-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["8383"],"URL":"https:\/\/doi.org\/10.1007\/s11606-023-08383-1","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"5 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors expressed no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}